TY - JOUR
T1 - Association of electroconvulsive therapy-induced structural plasticity with clinical remission
AU - Takamiya, Akihiro
AU - Kishimoto, Taishiro
AU - Hirano, Jinichi
AU - Kikuchi, Toshiaki
AU - Yamagata, Bun
AU - Mimura, Masaru
N1 - Funding Information:
This study is supported by Inokashira Hospital Grants for Psychiatry Research (2016–2017), Keio University Graduate School Grants for the Department of Neuropsychiatry (2017–2018), and AMED (Grant Number: JP20dm0307102h0003 ).
Funding Information:
This study is supported by Inokashira Hospital Grants for Psychiatry Research (2016?2017), Keio University Graduate School Grants for the Department of Neuropsychiatry (2017?2018), and AMED (Grant Number: JP20dm0307102h0003).
Funding Information:
AT has received grants from Keio University Medical Science Fund and Kanae Foundation for the Promotion of Medical Science. TKishimoto has received consultant fees from Otsuka, Pfizer, and Dainippon Sumitomo, and speaker's honoraria from Banyu, Eli Lilly, Dainippon Sumitomo, Janssen, Novartis, Otsuka, Takeda and Pfizer. TKikuchi has received speaker's honoraria from Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, MSD, Otsuka Pharmaceutical, Pfizer, Takeda Yakuhin, and Yoshitomi Yakuhin. MM has received grants and/or speaker's honoraria from Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin. JH and BY have nothing to declare.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/8/30
Y1 - 2021/8/30
N2 - Background: Electroconvulsive therapy (ECT) is the most effective treatment for severe depression. Recent neuroimaging studies have consistently reported that ECT induces volume increases in widely distributed brain regions. However, it still remains unclear about ECT-induced volume changes associated with clinical improvement. Methods: Longitudinal assessments of structural magnetic resonance imaging were conducted in 48 participants. Twenty-seven elderly melancholic depressed individuals (mean 67.5 ± 8.1 years old; 19 female) were scanned before (TP1) and after (TP2) ECT. Twenty-one healthy controls were also scanned twice. Whole-brain gray matter volume (GMV) was analyzed via group (remitters, nonremitters, and controls) by time (TP1 and TP2) analysis of covariance to identify ECT-related GMV changes and GMV changes specific to remitters. Within-subject and between-subjects correlation analyses were conducted to investigate the associations between clinical improvement and GMV changes. Depressive symptoms were evaluated using the 17-item Hamilton Depression Rating Scale (HAM-D), and remission was defined as HAM-D total score ≤ 7. Results: Bilateral ECT increased GMV in multiple brain regions bilaterally regardless of clinical improvement. Remitters showed a larger GMV increase in the right-lateralized frontolimbic brain regions compared to nonremitters and healthy controls. GMV changes in the right hippocampus/amygdala and right middle frontal gyrus showed correlations with clinical improvement in within−/between-subjects correlation analyses. Conclusions: ECT-induced GMV increase in the right frontolimbic regions was associated with clinical remission.
AB - Background: Electroconvulsive therapy (ECT) is the most effective treatment for severe depression. Recent neuroimaging studies have consistently reported that ECT induces volume increases in widely distributed brain regions. However, it still remains unclear about ECT-induced volume changes associated with clinical improvement. Methods: Longitudinal assessments of structural magnetic resonance imaging were conducted in 48 participants. Twenty-seven elderly melancholic depressed individuals (mean 67.5 ± 8.1 years old; 19 female) were scanned before (TP1) and after (TP2) ECT. Twenty-one healthy controls were also scanned twice. Whole-brain gray matter volume (GMV) was analyzed via group (remitters, nonremitters, and controls) by time (TP1 and TP2) analysis of covariance to identify ECT-related GMV changes and GMV changes specific to remitters. Within-subject and between-subjects correlation analyses were conducted to investigate the associations between clinical improvement and GMV changes. Depressive symptoms were evaluated using the 17-item Hamilton Depression Rating Scale (HAM-D), and remission was defined as HAM-D total score ≤ 7. Results: Bilateral ECT increased GMV in multiple brain regions bilaterally regardless of clinical improvement. Remitters showed a larger GMV increase in the right-lateralized frontolimbic brain regions compared to nonremitters and healthy controls. GMV changes in the right hippocampus/amygdala and right middle frontal gyrus showed correlations with clinical improvement in within−/between-subjects correlation analyses. Conclusions: ECT-induced GMV increase in the right frontolimbic regions was associated with clinical remission.
KW - Depression
KW - Electroconvulsive therapy (ECT)
KW - Gray matter volume (GMV)
KW - Magnetic resonance imaging (MRI)
KW - Remission
UR - http://www.scopus.com/inward/record.url?scp=85101836064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101836064&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2021.110286
DO - 10.1016/j.pnpbp.2021.110286
M3 - Article
C2 - 33621611
AN - SCOPUS:85101836064
SN - 0278-5846
VL - 110
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
M1 - 110286
ER -